HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 741.44 billion as of April 1, 2025. Its market cap has increased by 28.52% in one year.

Market Cap

741.44B

Enterprise Value

751.42B

Revenue

54.93B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,850.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 741.44B, an increase of 600.76%. That is a compound annual growth rate of 13.84%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	725.52B	-22.36%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	776.71B	0.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,537.79B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings